US Regulatory Considerations Applicable to Digital Health Providers and Suppliers - Part III: FDCA | K&L Gates LLP

This article examines another major regulatory regime relevant to mHealth application developers – the Federal Food, Drug and Cosmetic Act (FDCA), as well as regulatory issues unique to...

Related Keywords

United States , ,Enforcement Policy For Digital Health Devices ,Commission Act ,Kl Gates ,Regulatory Issues Unique To Companies ,Us Food Drug Administration ,Device Software Functions ,Public Health Emergency ,Federal Food ,Cosmetic Act ,Drug Administration ,Mobile Medical Applications Guidance ,Each Class ,General Controls ,Medical Device ,Device Reporting ,Premarket Notification ,Device Exemption ,Premarket Approval ,Certain Device Regulatory ,Institutional Review Board ,Coronavirus Disease ,Non Invasive Remote Monitoring Devices Used ,Support Patient Monitoring During ,Issues Unique ,Foreign Establishment ,Federal Trade Commission Act ,